Sterile CSP BUD vs. Expiration Date vs. Hang Time

A compounded sterile preparation’s beyond-use date (BUD) is the deadline for starting administration under the assigned storage and preparation conditions. It differs from the manufacturer’s expiration date on an ingredient and from an infusion’s hang time. USP says an infusion may finish after the BUD only when administration began before the BUD; a BUD is not extended by later refrigeration.

Three dates or periods, three questions

A manufacturer expiration date asks how long a manufactured product may be used in its original approved packaging and conditions. A BUD applies to a compounded preparation after it has been made. Hang time is the period a prepared infusion is administered to a patient. Similar-looking dates answer different questions; substituting one for another can lead to using a product outside its supported period.

What a BUD controls

USP defines the BUD as the date and time after which a CSP must not be used. For an infusion, the key point is when administration starts. The USP FAQ explains that administration cannot begin beyond the BUD, but an infusion that began before the BUD may finish afterward. Local policies and product-specific instructions still apply, especially if the product has a shorter limit.

The ingredient expiration does not become the CSP BUD

Compounding changes the preparation and may involve transfers, dilution, mixing, or a new container. The resulting CSP therefore has a BUD assigned under the applicable standard rather than automatically inheriting the longest expiration date printed on one ingredient. Before use, staff check the final preparation’s label, storage condition, and BUD, not just the source vial.

A later storage change does not reset the clock

USP’s FAQ says a BUD is not additive: moving a room-temperature preparation into refrigeration later does not extend its original BUD. Similarly, thawing a frozen item does not create a new period on top of the time already assigned. If a storage excursion occurs, follow the product-specific and facility escalation procedure; do not recalculate or extend the BUD independently.

Example: the infusion starts on time

Suppose a label says “Use by 14:00” and a nurse begins the infusion at 13:50. Under the USP FAQ principle, a properly started infusion may finish after 14:00. If the infusion has not started until 14:05, the BUD has passed and it must not be started. This example explains the distinction; the exact rules for a specific medication, container, or administration system must be checked with the pharmacist and policy.

Example: the vial is still in date

A manufactured sterile vial expires next month. It is used today to make a CSP with a much shorter assigned BUD. The final preparation must be used according to its own BUD. The vial’s original expiration does not authorize the CSP to be stored until next month. Conversely, if the source component is expired or compromised, the finished preparation cannot be rescued by assigning a new date.

Label and handoff checks

At the point of preparation or dispensing, verify that the label displays the correct BUD and any required storage condition. At handoff, communicate the deadline clearly to the clinician or receiving area. When a label is missing, illegible, inconsistent, or does not show a time where one is required, stop and obtain pharmacist clarification. Do not rely on a handwritten note from a previous shift.

Why storage conditions matter

The maximum BUD depends on category, method, environment, ingredients, storage, and supporting evidence under the current chapter. The BUD on the label is valid only if the preparation is stored as required. Refrigeration is not a universal extension mechanism, and room-temperature exposure may require action under facility procedure. Record and report a temperature excursion promptly.

PTCE traps to avoid

Do not equate a manufacturer expiration date with a compounded product’s BUD. Do not treat BUD and hang time as synonyms. Do not start a CSP after its BUD just because the infusion will be short. Do not extend the date after changing the storage location. The practical rule is: check the final CSP label and start administration by the BUD.

PTCE takeaway

Manufacturer expiration applies to the manufactured product; BUD applies to the compounded preparation; hang time describes administration duration. Start a CSP before its BUD. A started infusion may finish after the BUD under USP’s stated guidance, subject to product instructions and local policy. When unsure, hold and ask the pharmacist.

Operational detail to remember

The date and time must be interpreted in the preparation’s time zone and according to the label and facility procedure. Staff should pay particular attention to dates that fall during a shift handoff, overnight, or near the beginning of administration. If the receiving department has stored a preparation outside its required conditions, the printed BUD alone may not resolve the question; a temperature or handling excursion needs pharmacist review. The pharmacist may consult stability data, product instructions, and the facility’s excursion policy. A technician’s role is to catch the discrepancy early and relay the facts: when the CSP was made, how it was stored, when the infusion is scheduled, and what the label states. Never erase or relabel a BUD without authorization.

Key points to carry into practice

• A compounded sterile preparation’s beyond-use date (BUD) is the deadline for starting administration under the assigned storage and preparation conditions. It differs from the manufacturer’s expiration date on an ingredient and from an infusion’s hang time. USP says an infusion may finish after the BUD only when administration began before the BUD; a BUD is not extended by later refrigeration.
• Check the current official standard, payer guidance, or facility SOP for the exact requirement.
• Pause and escalate uncertainty instead of extending a date, bypassing a claim edit, or improvising a safety procedure.